Net Loss of Astec Lifesciences reported to Rs 24.43 crore in the quarter ended September 2025 as against net loss of Rs 38.56 crore during the previous quarter ended September 2024. Sales declined 25.20% to Rs 73.72 crore in the quarter ended September 2025 as against Rs 98.55 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales73.7298.55 -25 OPM %-9.07-20.03 - PBDT-13.97-27.07 48 PBT-24.41-38.54 37 NP-24.43-38.56 37 Powered by Capital Market - Live News

Net Loss of Astec Lifesciences reported to Rs 24.45 crore in the quarter ended September 2025 as against net loss of Rs 38.57 crore during the previous quarter ended September 2024. Sales declined 25.20% to Rs 73.72 crore in the quarter ended September 2025 as against Rs 98.55 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales73.7298.55 -25 OPM %-9.05-20.01 - PBDT-13.99-27.08 48 PBT-24.45-38.57 37 NP-24.45-38.57 37 Powered by Capital Market - Live News

Astec Lifesciences will hold a meeting of the Board of Directors of the Company on 29 October 2025.Powered by Capital Market - Live News

Net Loss of Astec Lifesciences reported to Rs 33.04 crore in the quarter ended June 2025 as against net loss of Rs 39.72 crore during the previous quarter ended June 2024. Sales rose 31.30% to Rs 91.08 crore in the quarter ended June 2025 as against Rs 69.37 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales91.0869.37 31 OPM %-12.07-66.67 - PBDT-21.52-52.37 59 PBT-33.02-61.64 46 NP-33.04-39.72 17 Powered by Capital Market - Live News

Astec Lifesciences will hold a meeting of the Board of Directors of the Company on 28 July 2025.Powered by Capital Market - Live News